119 related articles for article (PubMed ID: 8669155)
1. Differences in esophageal cancer treatments.
Skinner DB
World J Surg; 1996 May; 20(4):514. PubMed ID: 8669155
[No Abstract] [Full Text] [Related]
2. [Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with RO-resected esophageal carcinoma].
Mühlhöfer A; Kronawitter U; Zoller WG
Z Gastroenterol; 1998 May; 36(5):479-81. PubMed ID: 9654711
[No Abstract] [Full Text] [Related]
3. [Current theraphy of oesophageal cancer].
Baumhoer D; Ramadori G
Z Gastroenterol; 2004 Feb; 42(2):171-4. PubMed ID: 14963791
[No Abstract] [Full Text] [Related]
4. Extended resections in the management of esophageal carcinoma.
Altorki NK
Curr Opin Gen Surg; 1994; ():113-6. PubMed ID: 7583940
[TBL] [Abstract][Full Text] [Related]
5. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
6. [Lymphatic metastasis intensity of and lymphadenectomy for thoracic esophageal squamous cell carcinoma].
Lu ZM; Zhang H; Wang MH; Cui DH; Yang YQ; Huang HZ
Ai Zheng; 2006 May; 25(5):604-8. PubMed ID: 16687083
[TBL] [Abstract][Full Text] [Related]
7. The role of lymphadenectomy in esophageal cancer.
Darling G
J Surg Oncol; 2009 Mar; 99(4):189-93. PubMed ID: 19101951
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
[TBL] [Abstract][Full Text] [Related]
9. [The latest problems of surgery for cancer of the esophagus].
Nishihira T; Mori S; Sekine Y
Rinsho Kyobu Geka; 1987; 7(5):419-24. PubMed ID: 9301793
[No Abstract] [Full Text] [Related]
10. [Diagnostic relevance of lymph node size after 2-field lymph node excision in esophagus carcinomas].
Schröder W; Baldus SE; Mönig S; Zirbes TK; Dienes HP; Hölscher AH
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):501-3. PubMed ID: 14518306
[TBL] [Abstract][Full Text] [Related]
11. [Essential experience in surgical treatment of esophageal cancer in China over the past five decades].
Huang GJ
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):795-7. PubMed ID: 18396698
[No Abstract] [Full Text] [Related]
12. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
13. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
[TBL] [Abstract][Full Text] [Related]
14. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
[TBL] [Abstract][Full Text] [Related]
15. Transthoracic vs. transhiatal esophagectomy: Stage migration muddies the water.
Block MI
J Surg Oncol; 2006 Jun; 93(7):519-20. PubMed ID: 16705733
[No Abstract] [Full Text] [Related]
16. Survival and clinical evaluation of salvage operation for cervical lymph node recurrence in esophageal cancer.
Komatsu S; Shioaki Y; Ichikawa D; Hamashima T; Kan K; Ueshima Y; Koide K; Lee CJ; Ikeda E; Mutoh F; Kurioka H; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):796-9. PubMed ID: 15966207
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.
Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Nagasue N
Am J Surg; 2005 Jan; 189(1):98-109. PubMed ID: 15701501
[TBL] [Abstract][Full Text] [Related]
18. [Validity of thoraocscopic radical esophagectomy for cancer].
Osugi H; Takemura M; Lee S
Nihon Geka Gakkai Zasshi; 2005 May; 106(5):352-6. PubMed ID: 15934554
[No Abstract] [Full Text] [Related]
19. [Ivor Lewis esophagectomy with two-field lymph node dissection for squamous cell carcinoma of the lower thoracic esophagus].
Wu J; Chai Y; Zhou XM; Chen QX; Yan FL
Ai Zheng; 2007 Mar; 26(3):307-11. PubMed ID: 17355797
[TBL] [Abstract][Full Text] [Related]
20. [Esophageal cancer surgery; importance of surgical quality control].
Kajiyama Y; Iwanuma Y; Tomita N; Amano T; Isayama F; Tsurumaru M
Kyobu Geka; 2005 Jan; 58(1):58-65. PubMed ID: 15678968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
